Diagnostic Performance of Dual-time 18F-FDG PET in the Diagnosis of Pulmonary Nodules: A Meta-analysis

Academic Radiology

Volumn 19, Issue 2, 2012, Pages 153-158

  Barger, Richard L ^a   Nandalur, Kiran R ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

FDG PET; Meta analysis; Pulmonary nodule

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ARTICLE; DIAGNOSTIC TEST; EMBASE; EVIDENCE BASED MEDICINE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FOLLOW UP; HUMAN; LUNG NODULE; MEDLINE; META ANALYSIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; SOLITARY PULMONARY NODULE;

EID: 84855275339     PISSN: 10766332     EISSN: 18784046     Source Type: Journal    
DOI: 10.1016/j.acra.2011.10.009     Document Type: Article

References (24)

1. Rigo P., Paulus P., Kaschten B.J. Oncological applications of positron emission tomography with fluorine-18 glucose. Eur J Nucl Med 1996, 23:1641-1674.
2. Tan B.B., Flaherty K.R., Kazerooni E.A., et al. The solitary pulmonary nodule. Chest 2003, 123:89S-96S.
3. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011, 365:395-409. The National Lung Screening Trial Research Team.
4. Gould M., Fletcher J., Iannettoni M.D. Evaluation of patients with pulmonary nodules: when IS it lung cancer? ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition). Chest 2007, 132:108S-130S.
5. Gould M., Maclean C., Kuschner W., et al. Accuracy of positron emission tomography for the diagnosis of pulmonary nodules and mass lesions. JAMA 2001, 285:914-924.
6. Strauss L.G. Fluorine-18 glucose and false positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med 1996, 23:1409-1415.
7. 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med 2001, 42:1412-1417.
8. Flier J.S., Mueckler M.M., Usher P., et al. Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science 1987, 235:1492-1495.
9. Monakhov N.K., Neistadt E.L., Shavlovskil M.M., et al. Physicochemical properties and isoenzyme composition of hexokinase from normal and malignant human tissues. J Natl Cancer Inst 1978, 61:27-34.
10. Whiting P, Rutjes AW, Reitsma JB, etal. The development of QUADAS: a tool for the quality of assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. Available online at Accessed June 22, 2011. http://www.biomedcentral.com/1471-2288/3/25.
11. Zamora J, Abraira V, Muriel A, etal. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol. Available online at Accessed June 22, 2011. http://www.biomedcentral.com/1471-2288/6/31.
12. Fischer J.E., Bachmann L.M., Jaeschke R. A reader's guide to the interpretation of diagnostic test properties: clinical example of sepsis. Intensive Care Med 2003, 29:1043-1051.
13. Glas A.S., Lijmer J.G., Prins M.H., et al. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 2003, 56:1129-1135.
14. 18F-FDG PET imaging and partial volume correction in the assessment of solitary pulmonary nodules. Eur J Nucl Mol Imaging 2008, 35:246-252.
15. 18F-FDG PET in the diagnosis of pulmonary nodules with an initial standard uptake value less than 2.5. AJR Am J Roentgenol 2008, 191:475-479.
16. 18F-FDG-PET imaging for pulmonary lesions. Nucl Med Commun 2009, 30:455-461.
17. Cloran F., Banks K., Song W., et al. Limitations of dual time point PET in the assessment of lung nodules with low FDG avidity. Lung Cancer 2010, 68:66-71.
18. 18F-FDG PET imaging for the differentiation between malignant and benign lesions. Clin Radiol 2008, 63:756-764.
19. 18F-FDG PET for the evaluation of pulmonary nodules. J Nucl Med 2002, 43:871-875.
20. Nunez R., Kalapparambath A., Varela J. Improvement in sensitivity with delayed imaging of pulmonary lesions with FDG-PET. Rev Esp Med Nucl 2007, 26:196-207.
21. Schillaci O., Travascio L., Bolacchi F., et al. Accuracy of early and delayed FDG PET-CT and of contrast-enhanced CT in the evaluation of lung nodules: a preliminary study on 30 patients. Radiol Med 2009, 114:890-906.
22. Suga K., Kawakami Y., Hiyama A., et al. Dual time point 18F-FDG PET/CT scan for differentiation between 18F-FDG avid non small cell cancer and benign lesions. Ann Nucl Med 2009, 23:427-435.
23. Xiu Y., Bhutani C., Dhurairaj T., et al. Dual time point FDG PET imaging in the evaluation of pulmonary nodules with minimally increased metabolic activity. Clin Nucl Med 2007, 32:101-105.
24. Walker E., Hernandez A.V., Kattan M.W. Meta-analysis: Its strengths and limitations. Clevel Clin J Med 2008, 75:431-439.